Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alseres Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Magic RN who wrote (612)	12/12/1998 1:50:00 AM
From: JC Reddy	Read Replies (1) \| Respond to of 975

I don't know too much about the company, but from what I can see this seems like a good value investment. Are there any drugs waiting for FDA approval soon? It is interesting to see ZERO revenues for the last couple of quarters, but I think that will change with any FDA approval. Can someone tell me the risks involved here? Looks to me like a low risk, very high reward investment in the long run and potentially in the near term as well if any FDA approval comes along.

To: Magic RN who wrote (612)	1/25/1999 4:50:00 PM
From: robert heisman	Read Replies (1) \| Respond to of 975

Carole, I am an old old shareholder of this company. I was around when they merged. They have a history of being stagnant for a period of time and then off to the races. Problem is after the run up they usually take a big slide the other direction. I play the peaks and try to sell at what I think is a high. This is a great stock to run up and down on (buy low, sell high) can really do it with this one. They could very well hit it big and stay there some day soon but I really don't think the street of dreams is following this one. WHAT A SHAME. Bob H.